Loading clinical trials...
Loading clinical trials...
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vessel structure suitable for repair.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Kaiser Permanente
San Francisco, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
University of South Florida
Tampa, Florida, United States
Emory University
Atlanta, Georgia, United States
Methodist Hospital of Indiana
Indianapolis, Indiana, United States
Indiana Heart Hospital
Indianapolis, Indiana, United States
University of Michigan
Ann Arbor, Michigan, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Barnes-Jewish Hospital
St Louis, Missouri, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Start Date
March 1, 2010
Primary Completion Date
January 1, 2014
Completion Date
May 11, 2018
Last Updated
January 22, 2021
110
ACTUAL participants
Zenith® TX2® Low Profile TAA Endovascular Graft
DEVICE
Lead Sponsor
Cook Research Incorporated
NCT07241390
NCT03372733
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07473102